Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,872 | 50,482 | 81,553 | 155,700 | 171,223 |
| Marketable Securities | 41,106 | N/A | 121,898 | 266,308 | 233,967 |
| Receivables | 216 | 481 | 5,121 | 16,299 | 17,401 |
| Inventories | 3,743 | 3,155 | 17,173 | 40,436 | 31,015 |
| Other current assets | 0 | 110,849 | 65,776 | 0 | 0 |
| TOTAL | $99,073 | $196,509 | $331,559 | $492,826 | $474,059 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 4,785 | 20,605 | 28,277 |
| Investments And Advances | 20,160 | 0 | 0 | 9,409 | 171,621 |
| Other Non-Current Assets | 361 | 18,016 | 87,185 | 87,247 | 99,864 |
| TOTAL | $20,521 | $18,016 | $91,970 | $117,261 | $299,762 |
| Total Assets | $119,594 | $214,525 | $423,529 | $610,087 | $773,821 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,745 | 5,064 | 15,778 | 30,758 | 26,097 |
| Accrued Expenses | 20,183 | 62,035 | 132,987 | 219,773 | 172,599 |
| Other current liabilities | N/A | 38,917 | 43,516 | N/A | N/A |
| TOTAL | $29,242 | $133,306 | $217,668 | $273,562 | $225,497 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 73,092 | 71,934 | N/A | N/A |
| Deferred Revenues | 5,314 | 27,290 | 12,740 | 12,739 | 15,857 |
| Other Non-Current Liabilities | 107,102 | 98,534 | 160,051 | 152,283 | 132,410 |
| TOTAL | $107,357 | $286,334 | $389,540 | $338,005 | $319,211 |
| Total Liabilities | $136,599 | $419,640 | $607,208 | $611,567 | $544,708 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,047 | 4,037 | 3,951 | 3,767 | 3,720 |
| Common Shares | 1,012 | 1,009 | 988 | 942 | 929 |
| Retained earnings | -1,706,047 | -1,889,499 | -1,841,920 | -1,557,688 | -1,264,034 |
| Other shareholders' equity | 10,851 | 14,755 | 13,612 | 14,247 | 15,804 |
| TOTAL | $-17,005 | $-205,115 | $-183,679 | $-1,480 | $229,113 |
| Total Liabilities And Equity | $119,594 | $214,525 | $423,529 | $610,087 | $773,821 |